{"id":"https://openalex.org/W2094595413","doi":"https://doi.org/10.1371/journal.pone.0018552","title":"Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling","display_name":"Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling","alternate_titles":[],"publication_year":2011,"publication_date":"2011-04-14","ids":{"openalex":"https://openalex.org/W2094595413","doi":"https://doi.org/10.1371/journal.pone.0018552","mag":"2094595413","pmid":"https://pubmed.ncbi.nlm.nih.gov/21533169","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3077378"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0018552","doi":"https://doi.org/10.1371/journal.pone.0018552","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0018552","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0018552&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2094595413"],"child_works_count":11,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0018552&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057196078","display_name":"David A. Proia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David A. Proia","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America. DProia@syntapharma.com","Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America. DProia@syntapharma.com","institution_ids":["https://openalex.org/I4210158135"]},{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035181510","display_name":"Kevin P. Foley","orcid":"https://orcid.org/0000-0001-5148-7689","observed_orcids":["https://orcid.org/0000-0001-5148-7689"]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin P. Foley","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061021600","display_name":"Tim Korbut","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tim Korbut","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967092","display_name":"Jim Sang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jim Sang","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008756739","display_name":"Don Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don Smith","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051935182","display_name":"Richard C. Bates","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard C. Bates","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100390936","display_name":"Yuan Liu","orcid":"https://orcid.org/0000-0003-2668-0350","observed_orcids":["https://orcid.org/0000-0003-2668-0350"]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuan Liu","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008405026","display_name":"Alex F. Rosenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex F. Rosenberg","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101640481","display_name":"Dan Zhou","orcid":"https://orcid.org/0000-0001-8678-8270","observed_orcids":["https://orcid.org/0000-0001-8678-8270"]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Zhou","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111537027","display_name":"Keizo Koya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keizo Koya","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088509963","display_name":"James Barsoum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Barsoum","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080552253","display_name":"Ronald K. Blackman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald K. Blackman","raw_affiliation_strings":["Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210158135"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057196078"],"corresponding_institution_ids":["https://openalex.org/I4210158135"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":3.2594,"has_fulltext":true,"cited_by_count":80,"citation_normalized_percentile":{"value":0.93645278,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"6","issue":"4","first_page":"e18552","last_page":"e18552"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.7080000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.7080000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.24819999933242798,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ganetespib","display_name":"ganetespib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hsp90-inhibitors","display_name":"Hsp90 inhibitors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9599999785423279},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.925000011920929},{"id":"https://openalex.org/keywords/cell-cycle-regulation","display_name":"cell cycle regulation","score":0.8180000185966492},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.609000027179718},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.675000011920929},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2777560012","wikidata":"https://www.wikidata.org/wiki/Q5924361","display_name":"Hsp90 inhibitor","level":5,"score":0.6767058372497559},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5842581987380981},{"id":"https://openalex.org/C2778277574","wikidata":"https://www.wikidata.org/wiki/Q665327","display_name":"stat","level":4,"score":0.5353053212165833},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.49578985571861267},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4811224043369293},{"id":"https://openalex.org/C157333092","wikidata":"https://www.wikidata.org/wiki/Q902835","display_name":"JAK-STAT signaling pathway","level":4,"score":0.46962976455688477},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4408951997756958},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4183174669742584},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38800302147865295},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.30529874563217163},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2859020233154297},{"id":"https://openalex.org/C2775932338","wikidata":"https://www.wikidata.org/wiki/Q24772687","display_name":"Hsp90","level":4,"score":0.27497172355651855},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.10087814927101135},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08715483546257019},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.07422453165054321},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07198774814605713},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05216255784034729},{"id":"https://openalex.org/C205260736","wikidata":"https://www.wikidata.org/wiki/Q418939","display_name":"Heat shock protein","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018816","descriptor_name":"Genes, cdc","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D050791","descriptor_name":"STAT Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1371/journal.pone.0018552","doi":"https://doi.org/10.1371/journal.pone.0018552","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0018552","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0018552&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2092337","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3077378","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:21533169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21533169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3077378","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3077378/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:5f8979a9202f493f95717a8dd14439d5","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5f8979a9202f493f95717a8dd14439d5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 6, Iss 4, p e18552 (2011)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/137526","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Multifaceted_Intervention_by_the_Hsp90_Inhibitor_Ganetespib_STA_9090_in_Cancer_Cells_with_Activated_JAK_STAT_Signaling/137526","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.291.5369","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.291.5369","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/90/33/PLoS_One_2011_Apr_14_6(4)_e18552.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0018552","doi":"https://doi.org/10.1371/journal.pone.0018552","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0018552","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0018552&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2094595413.pdf","grobid_xml":"https://content.openalex.org/works/W2094595413.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1549647993","https://openalex.org/W1639450499","https://openalex.org/W1970700441","https://openalex.org/W1974679903","https://openalex.org/W1975225141","https://openalex.org/W1980568348","https://openalex.org/W1980814049","https://openalex.org/W1996172186","https://openalex.org/W1998055003","https://openalex.org/W2000929246","https://openalex.org/W2007106751","https://openalex.org/W2010326322","https://openalex.org/W2017715430","https://openalex.org/W2019114976","https://openalex.org/W2020391294","https://openalex.org/W2021425093","https://openalex.org/W2024282024","https://openalex.org/W2029318743","https://openalex.org/W2029663913","https://openalex.org/W2044227662","https://openalex.org/W2049145190","https://openalex.org/W2055061133","https://openalex.org/W2057360098","https://openalex.org/W2064840117","https://openalex.org/W2086435172","https://openalex.org/W2088357471","https://openalex.org/W2090231065","https://openalex.org/W2095801529","https://openalex.org/W2095898073","https://openalex.org/W2098731025","https://openalex.org/W2099805317","https://openalex.org/W2104485296","https://openalex.org/W2105949419","https://openalex.org/W2107282910","https://openalex.org/W2117479168","https://openalex.org/W2123080389","https://openalex.org/W2126665281","https://openalex.org/W2131384028","https://openalex.org/W2131822545","https://openalex.org/W2137158350","https://openalex.org/W2144198294","https://openalex.org/W2144664431","https://openalex.org/W2150627722","https://openalex.org/W2158156131","https://openalex.org/W2158217645","https://openalex.org/W2162423163","https://openalex.org/W2168586801","https://openalex.org/W2170910211","https://openalex.org/W2323400003","https://openalex.org/W2579219442","https://openalex.org/W2980047232"],"related_works":["https://openalex.org/W2323614657","https://openalex.org/W3175648470","https://openalex.org/W2095801529","https://openalex.org/W2564302543","https://openalex.org/W2245641415","https://openalex.org/W2248404724","https://openalex.org/W2083818823","https://openalex.org/W2063034486","https://openalex.org/W3046261291","https://openalex.org/W2144551737"],"abstract_inverted_index":{"There":[0],"is":[1],"accumulating":[2],"evidence":[3],"that":[4,47,74,139],"dysregulated":[5],"JAK":[6,36],"signaling":[7,163],"occurs":[8],"in":[9,19,23,59,62,65,89,120,169],"a":[10,66,185],"wide":[11],"variety":[12],"of":[13,27,68,92,103,131,154,172,200],"cancer":[14],"types.":[15],"In":[16,111],"particular,":[17],"mutations":[18],"JAK2":[20,78],"can":[21],"result":[22],"the":[24,48,95,115,197],"constitutive":[25],"activation":[26],"STAT":[28,104],"transcription":[29],"factors":[30],"and":[31,43,61,70,82,106,134,160,174],"lead":[32],"to":[33,165],"oncogenic":[34],"growth.":[35],"kinases":[37],"are":[38,75],"established":[39],"Hsp90":[40,52,182],"client":[41],"proteins":[42],"here":[44],"we":[45],"show":[46,138],"novel":[49,186],"small":[50],"molecule":[51],"inhibitor":[53,117],"ganetespib":[54,86,140,155,201],"(formerly":[55],"STA-9090)":[56],"exhibits":[57],"potent":[58,166],"vitro":[60],"vivo":[63],"activity":[64,79,105],"range":[67],"solid":[69],"hematological":[71],"tumor":[72],"cells":[73],"dependent":[76,192],"on":[77,124,156,193],"for":[80,189],"growth":[81,159],"survival.":[83],"Of":[84],"note,":[85],"treatment":[87,113],"results":[88,119],"sustained":[90],"depletion":[91],"JAK2,":[93],"including":[94],"constitutively":[96],"active":[97],"JAK2(V617F)":[98],"mutant,":[99],"with":[100,114,196],"subsequent":[101],"loss":[102],"reduced":[107],"STAT-target":[108],"gene":[109],"expression.":[110],"contrast,":[112],"pan-JAK":[116],"P6":[118,148],"only":[121],"transient":[122],"effects":[123],"these":[125,129],"processes.":[126],"Further":[127],"differentiating":[128],"modes":[130],"intervention,":[132],"RNA":[133],"protein":[135],"expression":[136],"studies":[137],"additionally":[141],"modulates":[142],"cell":[143,158,161],"cycle":[144],"regulatory":[145],"proteins,":[146],"while":[147],"does":[149],"not.":[150],"The":[151],"concomitant":[152],"impact":[153],"both":[157],"division":[162],"translates":[164],"antitumor":[167],"efficacy":[168],"mouse":[170],"models":[171],"xenografts":[173],"disseminated":[175],"JAK/STAT-driven":[176],"leukemia.":[177],"Overall,":[178],"our":[179],"findings":[180],"support":[181],"inhibition":[183],"as":[184],"therapeutic":[187],"approach":[188],"combating":[190],"diseases":[191],"JAK/STAT":[194],"signaling,":[195],"multimodal":[198],"action":[199],"demonstrating":[202],"advantages":[203],"over":[204],"JAK-specific":[205],"inhibitors.":[206]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2094595413","counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":18}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
